SCHEMBL15067759

SCHEMBL15067759

COC(c1ccccc1OC(F)(F)F)C1CC1c1cc(C)c(OC(C)(C)C(=O)O)c(C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 1.00
PPARD Q03181 16/20 1.00
PPARG P37231 14/20 1.00
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16243191 0.89 PPARG (0.80) PPARAPPARDPPARG
SCHEMBL15066833 0.86 PPARA (0.76) PPARAPPARDPPARG
SCHEMBL15067047 0.84 PPARG (0.72) PPARAPPARDPPARG
SCHEMBL15067511 0.83 PPARD (1.00) PPARAPPARDPPARG
SCHEMBL15067483 0.80 PPARD (0.76) PPARAPPARDPPARG
SCHEMBL15068170 0.80 PPARD (0.76) PPARAPPARDPPARG
SCHEMBL15067393 0.80 PPARD (1.00) PPARAPPARDPPARG
SCHEMBL15067564 0.79 PPARA (1.00) PPARAPPARDPPARG
SCHEMBL16242816 0.78 PPARG (0.64) PPARAPPARDPPARG
SCHEMBL16242996 0.77 PPARA (0.78) PPARAPPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9115073-B2 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2015-08-25 US claimed
EP-2811992-A1 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF Genfit (FR) 2014-12-17 EP claimed
US-20140350112-A1 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2014-11-27 US claimed
WO-2013098374-A1 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2013-07-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350112-A1 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF PPARD, PPARA, PPARG PPARA 2/4885PPARD 1/4885PPARG 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.